Alachua, FL (PRWEB) December 30, 2013
AxoGen, Inc. (NASDAQ: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, today announced that Navy Corpsman Edward Bonfiglio, a patient who received limb sparing surgery utilizing AxoGens Avance